6.	Common Stock.

The shareholders have authorized

100,000,000

shares of voting common shares for issuance. On

September 30, 2018,

a total of

45,968,528

shares of common stock were accounted for as previously issued (

37,299,276

), reserved for conversion of convertible debt to stock (

2,827,305

), as an issuance to

two

Company officers as compensation (

144,330

), and set aside for future issuance for private placement investments (

300,000

), warrants (

452,617

), qualified options (

950,000

), and nonqualified options (

3,995,000

March 10, 2016,

the Board of Directors approved the Company to enter into private placements for the sale of up to

5,000,000

shares of the Company’s common stock (Private Placement

2016

) at a price of

$.1875

per share (aggregate offering amount of

$937,500

September 30, 2016,

the Board of Directors approved the Company to amend the previously authorized Private Placement

2016

offer, sale, and issuance of unregistered securities. The Private Placement

2016

was amended to offer up to

10,000,000

shares of the Company’s common stock at a price of

$.1875

per share for an aggregate offering amount of

$1,875,000.

The offering was to be completed within

one

(

) year of the date of approval.

October 26, 2017,

The Board of Directors approved the Company to amend the previously authorized Private Placement

2016

offer, sale, and issuance of unregistered securities, such offering to be completed within

six

(

) months of the approval date of the amendment resolution. The Private Placement

2016

was amended to offer up to

15,000,000

shares of the Company’s common stock (in addition to any common stock issuable to satisfy conversion rights under the Convertible Promissory Notes offered in the Company’s Private Placement

2016

) at a price of

$.1875

per share for an aggregate offering amount of

$2,812,500.

During the

first

quarter of

2017,

the Company sold

270,000

shares of common stock at

$.1875

per share for proceeds of

$50,625.

stock was sold during the

second

quarter of

2017.

During

third

quarter of

2017,

the Company sold

500,000

shares of common stock at

$.1875

per share for aggregate proceeds of

$93,750.

One of the investors was ABI Chairman, CEO, and President, Stephen T. Chen, Ph.D. purchasing

200,000

common shares at

$.1875

per share for total proceeds of

$37,500.

During the

first

quarter of

2018,

7,579,059

shares of common stock were issued to investors from the

2016

offering at

$.1875

per share pursuant to a private placement subscription executed on

September 13, 2017.

The payments were received between

September 18, 2017

and

December 26, 2017.

Also in the

first

quarter of

2018,

1,901,941

shares of common stock were issued to investors from the

2016

offering at

$.25

per share pursuant to a private placement subscription executed and received on

April 25, 2018.

April 25, 2018,

The Board of Directors approved the Company to amend the previously authorized Private Placement

2016

off, sale and issuance of unregistered securities. The Private Placement

2016

was amended to offer up to

30,000,000

shares of the Company’s common stock at a price of

$.1875

per share for an aggregate offering amount of

$7,500,000.

Although the subscription was

not

executed until

April 25, 2018,

total funds of

$721,033

for

2,884,132

shares, were received in full by

December 26, 2017.

Since payment of the subscription was complete, the Company issued

1,901,941

shares of the stock early in the

first

quarter of

2018.

The remaining

982,191

shares were issued from the

2016

offering at

$.25

per share on

August 8, 2018,

as directed in the private placement subscription executed and received on

April 25, 2018,

856,843

shares valued at

$214,211

were issued as a commission for the private placement.

January 9, 2018,

Dr. Stephen T. Chen, Chairman, CEO, and President, and Bernard Cohen, CFO/VP, received

76,499

shares of common stock and

10,199

shares of common stock, respectively, as payment of the

fourth

quarter,

2017,

stock compensation award totaling

$21,250.

The stock was issued at a price of

$.2451

per share pursuant to the Board of Directors resolution of

December 20, 2016.

The shares are recognized as stock compensation expense for the quarter ended

December 31, 2017.

February 9, 2018,

Dr. Chen received

1,000,000

shares of ABI common stock as repayment for advancing

$187,500

between

March 18, 2016,

and

April 7, 2016,

as operating funds for ABI. The stock was issued at a price of

$.1875

per share.

Apri1

2018,

Dr. Chen converted

$178,125

of convertible notes payable for

950,000

common shares. The stock was issued at a price of

$.1875

per share as stated in the Note.

April 25, 2018

the

2016

Private Placement of the Company’s voting common stock was amended increasing the maximum shares in the offering to

million and the maximum proceeds to

$7.5

million. The offering was to be completed within

one

(

) year of the Board action.

July 12, 2018,

pursuant to an agreement executed

June 20, 2018,

ABI stock was issued to the

four

shareholders of ACTS, in exchange for the assets of that Taiwan Corporation. Each of the shareholders executed a stock power assigning the ACTS shares back to Dr. Stephen T. Chen, the CEO of ACTS. A total of

539,447

ABI Common voting shares were issued to:

Shareholder/Recipient	Issue Date	Number of Shares
Seu Chi Kuo	July 12, 2018		179,852
Po Ya Tseng	July 12, 2018		179,852
Yasushi Chikagami	July 12, 2018		53,891
Stephen/Virginia Chen Living Trust	July 12, 2018		125,852
Total			539,447

Dr. Chen is a related party insomuch as he is the CEO of ACTS and ABI.

August 21, 2018,

stock compensation was issued to Dr. Stephen T. Chen, CEO, and Bernard Cohen, CFO/VP for the

first

and

second

quarters of

2018

as follows:

Shareholder/Recipient	Quarter	Issue Date	Shares Issued		Share Price		Total Price
Stephen/Virginia Chen Living Trust	1 st	August 21, 2018		128,866	$	.1940	$	25,000
Stephen/Virginia Chen Living Trust	2 nd	August 21, 2018		91,254	$	.2740	$	25,000
Bernard Cohen	1 st	August 21, 2018		15,464	$	.1940	$	3,000
Bernard Cohen	2 nd	August 21, 2018		10,950	$	.2740	$	3,000
Total				246,534			$	56,000